Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Ying Luo

CEO at Gyre Therapeutics, Inc. (GYRE)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $83K

Reported trades

Filed Stock Type Shares Price Value Since
May 7SEC GYREGyre Therapeutics, Inc. Sell Plan 1792,575,362 held (−0%) $8.01 $1K -24.1%
May 7SEC GYREGyre Therapeutics, Inc. Sell Plan 10,1362,565,226 held (−0%) $8.04 $81K -24.4%
  • Sell

    CEO Ying Luo sold $1K of GYRE at $8.01 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Ying Luo sold $81K of GYRE at $8.04 — pre-scheduled 10b5-1 plan sale.